{"id":13239,"date":"2020-12-24T00:01:00","date_gmt":"2020-12-24T00:01:00","guid":{"rendered":"https:\/\/clinlabint.3wstaging.nl\/trimero-diagnostics-introduces-serum-amyloid-a-nephelometric-assay\/"},"modified":"2021-01-14T11:32:35","modified_gmt":"2021-01-14T11:32:35","slug":"trimero-diagnostics-introduces-serum-amyloid-a-nephelometric-assay","status":"publish","type":"post","link":"https:\/\/clinlabint.com\/trimero-diagnostics-introduces-serum-amyloid-a-nephelometric-assay\/","title":{"rendered":"TRIMERO Diagnostics introduces Serum Amyloid A nephelometric assay"},"content":{"rendered":"

TRIMERO Diagnostics has introduced an IVD CE-marked assay for testing Serum Amyloid A (SAA) on Beckman Coulter’s IMMAGE immunochemical systems.
\nThe key features of the assay are:<\/p>\n